|118.01||-3.36||-2.77%||Vol 270.55K||1Y Perf 164.44%|
|Apr 20th, 2021 16:00 DELAYED|
|- -||- -%|
|Target Price||143.25||Analyst Rating||Moderate Buy 2.38|
|Potential %||21.39||Finscreener Ranking||★★ 46.94|
|Insiders Trans % 3/6/12 mo.||-100/-100/-100||Value Ranking||★★ 47.31|
|Insiders Value % 3/6/12 mo.||-100/-100/-100||Growth Ranking||★★ 44.92|
|Insiders Shares Cnt. % 3/6/12 mo.||-100/-100/-100||Income Ranking||— -|
|Market Cap||3.75B||Earnings Rating||Neutral|
|Price Range Ratio 52W %||64.80||Earnings Date||10th May 2021|
Today's Price Range
|Earnings History||Estimate||Reported||Surprise %|
|Earnings Per End||Estimate||Revision %||Trend|
|Next Report Date||10th May 2021|
|Estimated EPS Next Report||-0.56|
|EPS Growth Next 5 Years %||-|
|Avg. Weekly Volume||461.88K|
|Avg. Monthly Volume||433.34K|
|Avg. Quarterly Volume||488.10K|
Cardlytics Inc. (NASDAQ: CDLX) stock closed at 118.01 per share at the end of the most recent trading day (a -2.77% change compared to the prior day closing price) with a volume of 271.60K shares and market capitalization of 3.75B. Is a component of indices and it is traded on NASDAQ exchange. The company belongs in the Interactive Media industry, Communication Services sector and employs 486 people. Cardlytics Inc. CEO is Lynne M. Laube.
The one-year performance of Cardlytics Inc. stock is 164.44%, while year-to-date (YTD) performance is -17.34%. CDLX stock has a five-year performance of %. Its 52-week range is between 38 and 161.47, which gives CDLX stock a 52-week price range ratio of 64.80%
Cardlytics Inc. currently has a PE ratio of -60.80, a price-to-book (PB) ratio of 25.07, a price-to-sale (PS) ratio of 27.87, a price to cashflow ratio of 291.80, a PEG ratio of 2.32, a ROA of -16.62%, a ROC of -19.70% and a ROE of -35.39%. The company’s profit margin is -29.63%, its EBITDA margin is -18.50%, and its revenue ttm is $141.38 Million , which makes it $4.45 revenue per share.
Of the last four earnings reports from Cardlytics Inc., there were 3 positive earnings surprise and 1 negative earnings surprise. The company has EPS estimate of $-0.56 for the next earnings report. Cardlytics Inc.’s next earnings report date is 10th May 2021.
The consensus rating of Wall Street analysts for Cardlytics Inc. is Moderate Buy (2.38), with a target price of $143.25, which is +21.39% compared to the current price. The earnings rating for Cardlytics Inc. stock is Neutral (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).
Cardlytics Inc. has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.
Cardlytics Inc. has a Neutral technical analysis rating based on Technical Indicators (ADX : 11.89, ATR14 : 9.78, CCI20 : 90.03, Chaikin Money Flow : 0.01, MACD : -5.29, Money Flow Index : 44.73, ROC : 10.64, RSI : 53.30, STOCH (14,3) : 80.36, STOCH RSI : 0.84, UO : 56.22, Williams %R : -19.64), Simple Moving Averages and Exponential Moving Averages.
Aggregated Insider Trades of Cardlytics Inc. in the last 12-months were: Andrew Christiansen (Option Excercise at a value of $241 868), Andrew Christiansen (Sold 20 286 shares of value $1 984 266 ), Bryce Youngren (Option Excercise at a value of $0), Bryce Youngren (Sold 10 000 shares of value $812 800 ), David L. Adams (Option Excercise at a value of $1 988 450), David L. Adams (Sold 63 750 shares of value $5 307 866 ), David T. Evans (Option Excercise at a value of $518 548), David T. Evans (Sold 77 796 shares of value $5 886 887 ), John L. Klinck (Option Excercise at a value of $0), John L. Klinck (Sold 23 904 shares of value $2 150 888 ), John V. Balen (Option Excercise at a value of $0), Kirk L. Somers (Option Excercise at a value of $576 221), Kirk L. Somers (Sold 92 684 shares of value $10 439 710 ), Lynne M. Laube (Option Excercise at a value of $142 372), Lynne M. Laube (Sold 74 400 shares of value $7 545 627 ), Mark A. Johnson (Option Excercise at a value of $0), Mark A. Johnson (Sold 312 304 shares of value $19 318 198 ), Scott D. Grimes (Option Excercise at a value of $0), Scott D. Grimes (Sold 512 357 shares of value $31 068 485 ), Tony Pavese (Option Excercise at a value of $0), Tony Pavese (Sold 11 904 shares of value $959 105 )
Copyright © 2016-2021 Finscreener.org. All Rights Reserved.
Disclaimer: Before deciding to trade you should carefully consider your investment objectives, level of experience and your risk appetite. Forex and Tradegate data is a real-time with a 30 second refresh. Prices may not be accurate and may differ from the actual market price. Prices on the website are indicative and solely for informational purposes, not for trading purposes or advice. Please be aware of the risks associated with trading the on financial markets, it is one of the riskiest investment forms. Past performance does not guarantee future profits. We take no responsibility for any losses that may arise as a result of the data contained on this website. The content and the website are provided "as is", without any warranties. In no event will Finscreener.org, its employees, owners, directors, affiliates, partners, data provider, third party or anyone else liable to anyone else for any decision made regarding information on this website.
This could take some time, please wait.